WELL Health Partners with AliveCor to Bring AI-Powered Portable ECG Devices to Canada

WELL Health Technologies has announced a partnership with AliveCor to introduce AI-powered cardiac monitoring solutions to Canadians. The collaboration aims to provide advanced heart health services, combining artificial intelligence technology with oversight from licensed cardiologists. This initiative seeks to enhance access to cardiac care and improve the detection and management of heart-related conditions.

AliveCor specializes in developing personal electrocardiogram (ECG) devices that utilize AI algorithms for analyzing heart activity. Through this partnership, WELL Health will integrate AliveCor’s technology into its network of healthcare providers across Canada. Patients will have access to portable ECG devices capable of detecting potential abnormalities such as atrial fibrillation, bradycardia, tachycardia, and other arrhythmias. Cardiologists within WELL Health’s ecosystem will oversee the results generated by these devices, ensuring accurate interpretation and appropriate follow-up care when necessary.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 2, 2026

Author

GOAI